Skip to main content

Advertisement

Log in

Therapeutic keratoplasty for severe Acanthamoeba keratitis: risk factors, clinical features, and outcomes of postoperative recurrence

  • Cornea
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To investigate the effect of therapeutic keratoplasty (TKP) in patients with severe Acanthamoeba keratitis (AK) and to analyse the clinical features and risk factors for recurrence.

Methods

Clinical data of patients with severe AK treated with lamellar keratoplasty (LK) or penetrating keratoplasty (PK) due to ineffective drug therapy were analysed in this retrospective study. The effects of keratoplasty, clinical features, and risk factors for recurrence were analysed.

Results

The cohort comprised of 58 patients (59 eyes). Of these, 36 eyes were treated with PK and 23 were treated with LK. The probabilities of successful globe salvage were 91.7% and 91.3%, respectively. The final visual acuity (VA) was ≥ 20/60 in 14 eyes (38.9%) that underwent PK and 15 eyes (65.2%) that underwent LK. Postoperative recurrence of Acanthamoeba infection was detected in 10 eyes; 6 eyes (16.7%) showed recurrence after PK, and 4 eyes (17.4%) showed recurrence after LK. Recurrence occurred between 3 and 80 days (median, 14.5 days) after the operation. The risk factors for recurrence after LK were topical corticosteroid use before diagnosis (p = 0.040) and hypopyon (p = 0.009), while those after PK were topical corticosteroid use before diagnosis (p = 0.045). Clinical manifestations of postoperative recurrence include greyish-white infiltration of the recipient bed, anterior chamber inflammation, graft oedema, and keratic precipitate.

Conclusion

TKP is a treatment option for severe AK that responds poorly to antiamoebic therapy (AAT), although Acanthamoeba infection may relapse, and the visual prognosis is guarded. Topical corticosteroid use before AAT and hypopyon is the two risk factors for recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Clarke DW, Niederkorn JY (2006) The pathophysiology of Acanthamoeba keratitis. Trends Parasitol 22:175–180. https://doi.org/10.1016/j.pt.2006.02.004

    Article  CAS  PubMed  Google Scholar 

  2. Panjwani N (2010) Pathogenesis of Acanthamoeba keratitis. Ocul Surf 8:70–79. https://doi.org/10.1016/s1542-0124(12)70071-x

    Article  PubMed  PubMed Central  Google Scholar 

  3. Lorenzo-Morales J, Martín-Navarro CM, López-Arencibia A, Arnalich-Montiel F, Pinero JE, Valladares B (2013) Acanthamoeba keratitis: an emerging disease gathering importance worldwide? Trends Parasitol 29:181–187. https://doi.org/10.1016/j.pt.2013.01.006

    Article  PubMed  Google Scholar 

  4. Aksozek A, McClellan K, Howard K, Niederkorn JY, Alizadeh H (2002) Resistance of Acanthamoeba castellanii cysts to physical, chemical, and radiological conditions. J Parasitol 88(3):621–623. https://doi.org/10.1645/0022-3395(2002)088[0621:ROACCT]2.0.CO;2

    Article  CAS  PubMed  Google Scholar 

  5. Papa V, Rama P, Radford C, Minassian DC, Dart JKG (2020) Acanthamoeba keratitis therapy: time to cure and visual outcome analysis for different antiamoebic therapies in 227 cases. Br J Ophthalmol 104:575–581. https://doi.org/10.1136/bjophthalmol-2019-314485

    Article  PubMed  Google Scholar 

  6. Carnt N, Robaei D, Minassian DC, Dart JKG (2018) Acanthamoeba keratitis in 194 patients: risk factors for bad outcomes and severe inflammatory complications. Br J Ophthalmol 102:1431–1435. https://doi.org/10.1136/bjophthalmol-2017-310806

    Article  PubMed  Google Scholar 

  7. Robaei D, Carnt N, Minassian DC, Dart JK (2015) Therapeutic and optical keratoplasty in the management of Acanthamoeba keratitis: risk factors, outcomes, and summary of the literature. Ophthalmology 122:17–24. https://doi.org/10.1016/j.ophtha.2014.07.052

    Article  PubMed  Google Scholar 

  8. Awwad ST, Pamar DN, Heilman M, Bowman RW, McCulley JP, Cavanagh HD (2005) Results of penetrating keratoplasty for visual rehabilitation after Acanthamoeba keratitis. Am J Ophthalmol 140:1080–1084. https://doi.org/10.1016/j.ajo.2005.07.031

    Article  PubMed  Google Scholar 

  9. Kitzmann AS, Goins KM, Sutphin JE, Wagoner MD (2009) Keratoplasty for treatment of Acanthamoeba keratitis. Ophthalmology 116:864–869. https://doi.org/10.1016/j.ophtha.2008.12.029

    Article  PubMed  Google Scholar 

  10. Hargrave SL, McCulley JP, Husseini Z (1999) Results of a trial of combined propamidine isethionate and neomycin therapy for Acanthamoeba keratitis: Brolene Study Group. Ophthalmology 106:952–957. https://doi.org/10.1016/s0161-6420(99)00515-1

    Article  CAS  PubMed  Google Scholar 

  11. Ficker LA, Kirkness C, Wright P (1993) Prognosis for keratoplasty in Acanthamoeba keratitis. Ophthalmology 100:105–110. https://doi.org/10.1016/s0161-6420(93)31707-0

    Article  CAS  PubMed  Google Scholar 

  12. Kashiwabuchi RT, de Freitas D, Alvarenga LS, Vieira L, Contarini P, Sato E, Foronda A (2008) Hofling-Lima AL (2008) Corneal graft survival after therapeutic keratoplasty for Acanthamoeba keratitis. Acta Ophthalmol 86:666–669. https://doi.org/10.1111/j.1600-0420.2007.01086.x

    Article  PubMed  Google Scholar 

  13. Sarnicola E, Sarnicola C, Sabatino F, Tosi GM, Perri P, Sarnicola V (2016) Early deep anterior lamellar keratoplasty (DALK) for Acanthamoeba keratitis poorly responsive to medical treatment. Cornea 35(1):1–5. https://doi.org/10.1097/ICO.0000000000000681

    Article  PubMed  Google Scholar 

  14. Anshu A, Parthasarathy A, Mehta JS, Htoon HM, Tan DTH (2009) Outcomes of therapeutic deep lamellar keratoplasty and penetrating keratoplasty for advanced infectious keratitis: a comparative study. Ophthalmology 116:615–623. https://doi.org/10.1016/j.ophtha.2008.12.043

    Article  PubMed  Google Scholar 

  15. Robaei D, Carnt N, Minassian DC, Dart JKG (2014) The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis. Ophthalmology 121:1383–1388. https://doi.org/10.1016/j.ophtha.2014.01.031

    Article  PubMed  Google Scholar 

  16. Carnt N, Robaei D, Watson SL, Minassian DC, Dart JKG (2016) The impact of topical corticosteroids used in conjunction with antiamoebic therapy on the outcome of Acanthamoeba keratitis. Ophthalmology 123:984–990. https://doi.org/10.1016/j.ophtha.2016.01.020

    Article  PubMed  Google Scholar 

  17. McClellan K, Howard K, Niederkorn JY, Alizadeh H (2001) Effect of steroids on Acanthamoeba cysts and trophozoites. Invest Ophthalmol Vis Sci 42:2885–2893

    CAS  PubMed  Google Scholar 

  18. Davis MJ, Packo KH, Epstein RJ, Grostern RJ, Cohen JA (2010) Acanthamoeba endophthalmitis following penetrating keratoplasty for Acanthamoeba keratitis. Arch Ophthalmol 128:505–506. https://doi.org/10.1001/archophthalmol.2010.33

    Article  PubMed  Google Scholar 

  19. Moshari A, McLean IW, Dodds MT, Damiano RE, McEvoy PL (2001) Chorioretinitis after keratitis caused by Acanthamoeba: case report and review of the literature. Ophthalmology 108:2232–2236. https://doi.org/10.1016/s0161-6420(01)00765-5

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study was partially supported by the Academic Promotion Program and Innovation Project of Shandong First Medical University (2019ZL001 and 2019RC008).

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to study conception and design. Jun Cheng designed the review protocol, wrote the protocol, conducted the search, and screened the potentially eligible studies. Ting Zhang was responsible for writing the report, extracting and analysing data, conducting the statistical analyses, interpreting results, updating reference lists, and creating tables. Lixin Xie and Yanling Dong contributed to data extraction and provided feedback regarding the report. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Jun Cheng.

Ethics declarations

Ethical approval

All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Ethics Committee of Qingdao Eye Hospital affiliated to Shandong first Medical University) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, T., Xie, L., Dong, Y. et al. Therapeutic keratoplasty for severe Acanthamoeba keratitis: risk factors, clinical features, and outcomes of postoperative recurrence. Graefes Arch Clin Exp Ophthalmol 261, 1299–1309 (2023). https://doi.org/10.1007/s00417-022-05883-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-022-05883-4

Keywords

Navigation